New hepatitis C antiviral treatments eliminate the virus

Grants

Funding Acknowledgements

All authors declare investigator-initiated research funding from Gilead Sciences; JSD, AJT, and MEH declare investigator-initiated research support from Abbvie, Merck, and Bristol-Myers Squibb. JSD and AJT declare honoraria from Gilead Sciences, Merck, Bristol-Myers Squibb, Roche, and Abbvie. JSD, AJT, MS, PMD, and MEH declare fellowship support from the National Health and Medical Research Council of Australia. Burnet Institute receives support from the Victorian Government Operational Infrastructure Fund.